Literature DB >> 9870612

The rodent alphaA-crystallin gene: mutagenesis of a non-consensus 5'-splice site to study alternative splicing in vivo.

R H Smulders1, B P Kokke, M L Gijsen, W W de Jong.   

Abstract

alphaA-Crystallin is a member of the small heat shock protein family that is abundantly expressed as a structural component in the vertebrate eye lens. In lenses of rodents and some other mammals, there occurs a minor variant of alphaA-crystallin, which has an insertion of 23 amino acid residues. This variant, alphaA(ins)-crystallin, results from differential integration of an optional exon into a small fraction of the mRNA. We have studied whether this alternative splicing is caused by a non-consensus cytosine in the 5' splice site adjacent to the optional exon. After replacement of the aberrant cytosine in the hamster alphaA-crystallin gene by a consensus thymine, and transient transfection of this gene in Chinese Hamster Ovary cells, the optional exon is indeed almost completely spliced into the mature mRNA. In contrast, replacement of the cytosine by adenine or guanine completely abolishes the splicing of the optional exon. Our results confirm that alternative splicing of the alphaA-crystallin primary transcript is mainly due to a non-consensus 5' splice site nucleotide. However, we conclude that the small size of the optional exon is probably an additional contributing factor and therefore it seems that the splicing mechanism is based on recognition of exons rather than introns.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9870612     DOI: 10.1023/a:1006897910253

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

Review 1.  A reappraisal of non-consensus mRNA splice sites.

Authors:  I J Jackson
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

2.  5' cleavage site in eukaryotic pre-mRNA splicing is determined by the overall 5' splice region, not by the conserved 5' GU.

Authors:  M Aebi; H Hornig; C Weissmann
Journal:  Cell       Date:  1987-07-17       Impact factor: 41.582

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  A pseudo-exon in the functional human alpha A-crystallin gene.

Authors:  C J Jaworski; J Piatigorsky
Journal:  Nature       Date:  1989-02-23       Impact factor: 49.962

Review 5.  The superfamily of arginine/serine-rich splicing factors.

Authors:  X D Fu
Journal:  RNA       Date:  1995-09       Impact factor: 4.942

6.  The expanding small heat-shock protein family, and structure predictions of the conserved "alpha-crystallin domain".

Authors:  G J Caspers; J A Leunissen; W W de Jong
Journal:  J Mol Evol       Date:  1995-03       Impact factor: 2.395

7.  Reduced chaperone-like activity of alpha A(ins)-crystallin, an alternative splicing product containing a large insert peptide.

Authors:  R H Smulders; I G van Geel; W L Gerards; H Bloemendal; W W de Jong
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

8.  Internally elongated rodent alpha-crystallin A chain: resulting from incomplete RNA splicing?

Authors:  W W de Jong; L H Cohen; J A Leunissen; A Zweers
Journal:  Biochem Biophys Res Commun       Date:  1980-09-30       Impact factor: 3.575

9.  The tyrosinase-related protein-1 gene has a structure and promoter sequence very different from tyrosinase.

Authors:  I J Jackson; D M Chambers; P S Budd; R Johnson
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

10.  Identification of a mutation that causes exon skipping during collagen pre-mRNA splicing in an Ehlers-Danlos syndrome variant.

Authors:  D Weil; M Bernard; N Combates; M K Wirtz; D W Hollister; B Steinmann; F Ramirez
Journal:  J Biol Chem       Date:  1988-06-25       Impact factor: 5.157

View more
  1 in total

1.  Exon shuffling mimicked in cell culture.

Authors:  A A van Rijk; W W de Jong; H Bloemendal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.